|
PUT
|
$6,000
|
5.1K
|
Q2 2025
Reduced 17.74%
|
|
|
CALL
|
$110,000
|
3.7K
|
Q2 2025
Reduced 90.39%
|
|
|
PUT
|
$56,000
|
1.9K
|
Q2 2025
Added 18.75%
|
|
|
CALL
|
$76,000
|
11.7K
|
Q2 2025
Added 116.67%
|
|
|
PUT
|
$20,000
|
3.1K
|
Q2 2025
Reduced 59.74%
|
|
|
CALL
|
$13,000
|
600
|
Q2 2025
Reduced 85.37%
|
|
|
PUT
|
$152,000
|
6.8K
|
Q2 2025
Added 325.0%
|
|
|
CALL
|
$104,000
|
1K
|
Q2 2025
Added 150.0%
|
|
|
PUT
|
$62,000
|
600
|
Q2 2025
Reduced 95.52%
|
|
|
CALL
|
$145,000
|
1.3K
|
Q2 2025
Reduced 76.79%
|
|
|
PUT
|
$67,000
|
600
|
Q2 2025
Reduced 50.0%
|
|
|
CALL
|
$2.2 Million
|
15.3K
|
Q2 2025
Added 30.77%
|
|
|
PUT
|
$57,000
|
400
|
Q2 2025
Reduced 97.56%
|
|
|
CALL
|
$2.03 Million
|
94.1K
|
Q2 2025
Added 14.9%
|
|
Mirum Pharmaceuticals Inc
|
CALL
|
$147,000
|
2.9K
|
Q2 2025
Reduced 6.45%
|
|
Milestone Pharmaceuticals In
|
CALL
|
$245,000
|
127K
|
Q2 2025
Added 165.27%
|
|
Milestone Pharmaceuticals In
|
PUT
|
$13,000
|
7K
|
Q2 2025
Reduced 30.0%
|
|
|
CALL
|
$10,000
|
1.1K
|
Q2 2025
Reduced 31.25%
|
|
|
PUT
|
$24,000
|
2.5K
|
Q1 2025
Added 13.64%
|
|
|
CALL
|
$19,000
|
2.6K
|
Q2 2025
Reduced 21.21%
|
|
|
PUT
|
$0
|
100
|
Q2 2025
Reduced 66.67%
|
|
|
CALL
|
$2.42 Million
|
31.9K
|
Q2 2025
Added 43.69%
|
|
|
PUT
|
$2.96 Million
|
39K
|
Q2 2025
Added 57.89%
|
|
|
CALL
|
$1.8 Million
|
900
|
Q2 2025
Added 80.0%
|
|
|
PUT
|
$1.2 Million
|
600
|
Q2 2025
New holding
|
|
|
CALL
|
$1.86 Million
|
18.7K
|
Q2 2025
Added 246.3%
|
|
|
PUT
|
$635,000
|
6.4K
|
Q2 2025
Reduced 45.3%
|
|
|
CALL
|
$1.59 Million
|
7.1K
|
Q2 2025
Reduced 69.92%
|
|
|
PUT
|
$67,000
|
300
|
Q2 2025
Reduced 86.96%
|
|
Melco Resorts And Entmnt LTD
|
CALL
|
$892,000
|
124K
|
Q2 2025
Reduced 54.8%
|
|
Melco Resorts And Entmnt LTD
|
PUT
|
$933,000
|
129K
|
Q2 2025
Added 4.53%
|
|
|
CALL
|
$16,000
|
133K
|
Q2 2025
New holding
|
|
|
PUT
|
$20,000
|
26.3K
|
Q2 2025
Added 5160.0%
|
|
|
CALL
|
$1 Million
|
12.6K
|
Q2 2025
Added 26.0%
|
|
|
PUT
|
$7,000
|
100
|
Q2 2025
Reduced 97.73%
|
|
|
CALL
|
$1,000
|
100
|
Q2 2025
New holding
|
|
|
PUT
|
$201,000
|
10.4K
|
Q2 2025
Reduced 46.39%
|
|
Martin Marietta Matls Inc
|
CALL
|
$768,000
|
1.4K
|
Q2 2025
Reduced 26.32%
|
|
Martin Marietta Matls Inc
|
PUT
|
$3.02 Million
|
5.5K
|
Q2 2025
Reduced 1.79%
|
|
|
CALL
|
$14,000
|
900
|
Q2 2025
Added 12.5%
|
|
|
CALL
|
$4,000
|
100
|
Q1 2025
New holding
|
|
Moonlake Immunotherapeutics
|
CALL
|
$736,000
|
15.6K
|
Q2 2025
Reduced 28.44%
|
|
Moonlake Immunotherapeutics
|
PUT
|
$1.11 Million
|
23.5K
|
Q2 2025
New holding
|
|
Mineralys Therapeutics Inc
|
CALL
|
$12,000
|
900
|
Q2 2025
Reduced 84.75%
|
|
|
CALL
|
$3.17 Million
|
14.5K
|
Q2 2025
Added 21.85%
|
|
|
PUT
|
$5.16 Million
|
23.6K
|
Q2 2025
Added 43.03%
|
|
|
CALL
|
$18,000
|
600
|
Q2 2025
New holding
|
|
Martin Midstream Prtnrs L P
|
CALL
|
$5,000
|
1.9K
|
Q1 2025
Added 1800.0%
|
|
|
CALL
|
$21,000
|
300
|
Q2 2025
New holding
|
|
|
CALL
|
$420,000
|
4.5K
|
Q2 2025
New holding
|
|